About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 3NCT01084005

Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes

The objective of the current study is to investigate the efficacy, safety and tolerability of linagliptin (5 mg / once daily) compared to placebo given for 24 weeks as add-on therapy to stable treatme...

Lead sponsor: Boehringer Ingelheim•34 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Boehringer Ingelheim

Collaborators

Eli Lilly and Company

Age

70 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Type 2 diabetes mellitus
•2. HbA1c \>= 7.0%
•3. Age \>= 70 years
•4. Signed and dated written informed consent

Exclusion Criteria

•1. Myocardial infarction, stroke or TIA within 3 months prior to informed consent
•2. Impaired hepatic function
•3. Treatment with glitazones, GLP-1 analogues, DPP-4 inhibitors or rapid acting or pre-mixed insulins
•4. Treatment with anti-obesity drugs

Related studies

Milk for Diabetes Prevention

NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more

RECRUITINGPhase 4

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

NCT07112339 · Diabetes Mellitus, Type 2

Food Insecurity Reduction & Strategy Team

NCT06329375 · Diabetes Mellitus, Type 2, Food Insecurity, and more

RECRUITINGPhase 1

A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes

NCT06945406 · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

NCT06959901 · Obesity and Diabetes Mellitus, Type 2, Diabetes Prevention

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 29, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment241

Start dateMar 2010

Last updatedJan 29, 2014

Condition

Diabetes Mellitus, Type 2

Locations shown

1218.63.61005 Boehringer Ingelheim Investigational Site

Gosford, New South Wales

1218.63.61006 Boehringer Ingelheim Investigational Site

Herston, Queensland

1218.63.61003 Boehringer Ingelheim Investigational Site

Adelaide, South Australia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2014Data synced to Clareo: May 24, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions